A phase II trial evaluating the efficacy and safety of epirubicin and cyclophosphamide (EC) followed by docetaxel with gemcitabine (DG) (+trastuzumab if HER2-positive) as neoadjuvant chemotherapy for women with large operable or locally advanced breast carcinoma (ANZ 0502 NeoGem)
收藏DataCite Commons2023-06-08 更新2024-07-13 收录
下载链接：
https://doi.breastcancertrials.org.au/9
下载链接
链接失效反馈官方服务：
资源简介：
HeSANDA 1.0.0
HeSANDA 1.0.0
提供机构：
Breast Cancer Trials (BCT)
创建时间：
2023-05-31
